Annual CFO
-$19.43 M
+$108.35 M+84.79%
31 December 2023
Summary:
Wave Life Sciences annual cash flow from operations is currently -$19.43 million, with the most recent change of +$108.35 million (+84.79%) on 31 December 2023. During the last 3 years, it has risen by +$96.55 million (+83.25%). WVE annual CFO is now -447.20% below its all-time high of -$3.55 million, reached on 31 December 2013.WVE Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$46.48 M
-$19.01 M-69.21%
30 September 2024
Summary:
Wave Life Sciences quarterly cash flow from operations is currently -$46.48 million, with the most recent change of -$19.01 million (-69.21%) on 30 September 2024. Over the past year, it has dropped by -$12.02 million (-34.89%). WVE quarterly CFO is now -154.35% below its all-time high of $85.52 million, reached on 31 March 2023.WVE Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$140.62 M
-$12.02 M-9.35%
30 September 2024
Summary:
Wave Life Sciences TTM cash flow from operations is currently -$140.62 million, with the most recent change of -$12.02 million (-9.35%) on 30 September 2024. Over the past year, it has dropped by -$120.98 million (-616.26%). WVE TTM CFO is now -8585.42% below its all-time high of -$1.62 million, reached on 31 March 2015.WVE TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
WVE Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +84.8% | -34.9% | -616.3% |
| 3 y3 years | +83.3% | -64.9% | -24.0% |
| 5 y5 years | +15.0% | -6.4% | +12.0% |
WVE Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +84.8% | -154.3% | at low | -5793.4% | at low |
| 5 y | 5 years | at high | +89.7% | -154.3% | +24.1% | -5793.4% | +25.3% |
| alltime | all time | -447.2% | +89.7% | -154.3% | +24.1% | -8585.4% | +25.3% |
Wave Life Sciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$46.48 M(+69.2%) | -$140.62 M(+9.3%) |
| June 2024 | - | -$27.47 M(-17.8%) | -$128.60 M(-7.1%) |
| Mar 2024 | - | -$33.43 M(+0.6%) | -$138.38 M(+612.2%) |
| Dec 2023 | -$19.43 M(-84.8%) | -$33.24 M(-3.5%) | -$19.43 M(-1.0%) |
| Sept 2023 | - | -$34.46 M(-7.5%) | -$19.63 M(+81.4%) |
| June 2023 | - | -$37.26 M(-143.6%) | -$10.82 M(+353.5%) |
| Mar 2023 | - | $85.52 M(-355.7%) | -$2.39 M(-98.1%) |
| Dec 2022 | -$127.78 M(+43.6%) | -$33.44 M(+30.4%) | -$127.78 M(+26.0%) |
| Sept 2022 | - | -$25.65 M(-11.0%) | -$101.37 M(-2.4%) |
| June 2022 | - | -$28.82 M(-27.7%) | -$103.91 M(+23.0%) |
| Mar 2022 | - | -$39.87 M(+466.9%) | -$84.49 M(-5.1%) |
| Dec 2021 | -$88.99 M(-23.3%) | -$7.03 M(-75.0%) | -$88.99 M(-21.5%) |
| Sept 2021 | - | -$28.18 M(+199.8%) | -$113.38 M(+7.6%) |
| June 2021 | - | -$9.40 M(-78.8%) | -$105.36 M(-21.4%) |
| Mar 2021 | - | -$44.38 M(+41.3%) | -$134.11 M(+15.6%) |
| Dec 2020 | -$115.98 M(-38.4%) | -$31.41 M(+55.7%) | -$115.98 M(-20.5%) |
| Sept 2020 | - | -$20.17 M(-47.1%) | -$145.81 M(-13.9%) |
| June 2020 | - | -$38.15 M(+45.3%) | -$169.32 M(+3.2%) |
| Mar 2020 | - | -$26.25 M(-57.1%) | -$164.10 M(-12.8%) |
| Dec 2019 | -$188.23 M | -$61.24 M(+40.2%) | -$188.23 M(+17.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | -$43.68 M(+32.7%) | -$159.81 M(+10.1%) |
| June 2019 | - | -$32.93 M(-34.6%) | -$145.14 M(+255.6%) |
| Mar 2019 | - | -$50.38 M(+53.5%) | -$40.82 M(+78.5%) |
| Dec 2018 | -$22.86 M(-72.7%) | -$32.82 M(+13.1%) | -$22.86 M(+78.7%) |
| Sept 2018 | - | -$29.01 M(-140.6%) | -$12.80 M(+77.8%) |
| June 2018 | - | $71.39 M(-320.2%) | -$7.20 M(-92.7%) |
| Mar 2018 | - | -$32.43 M(+42.5%) | -$98.68 M(+17.9%) |
| Dec 2017 | -$83.67 M(+162.1%) | -$22.75 M(-2.8%) | -$83.67 M(+12.7%) |
| Sept 2017 | - | -$23.41 M(+16.5%) | -$74.26 M(+18.5%) |
| June 2017 | - | -$20.09 M(+15.3%) | -$62.69 M(+48.5%) |
| Mar 2017 | - | -$17.42 M(+30.5%) | -$42.21 M(+32.2%) |
| Dec 2016 | -$31.93 M(+154.8%) | -$13.35 M(+12.8%) | -$31.93 M(+26.5%) |
| Sept 2016 | - | -$11.83 M(-3133.8%) | -$25.25 M(+55.2%) |
| June 2016 | - | $390.00 K(-105.5%) | -$16.26 M(-9.9%) |
| Mar 2016 | - | -$7.14 M(+7.0%) | -$18.04 M(+44.0%) |
| Dec 2015 | -$12.53 M(+183.0%) | -$6.67 M(+134.1%) | -$12.53 M(+113.8%) |
| Sept 2015 | - | -$2.85 M(+104.6%) | -$5.86 M(+94.6%) |
| June 2015 | - | -$1.39 M(-14.0%) | -$3.01 M(+86.0%) |
| Mar 2015 | - | -$1.62 M | -$1.62 M |
| Dec 2014 | -$4.43 M(+24.6%) | - | - |
| Dec 2013 | -$3.55 M | - | - |
FAQ
- What is Wave Life Sciences annual cash flow from operations?
- What is the all time high annual CFO for Wave Life Sciences?
- What is Wave Life Sciences annual CFO year-on-year change?
- What is Wave Life Sciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Wave Life Sciences?
- What is Wave Life Sciences quarterly CFO year-on-year change?
- What is Wave Life Sciences TTM cash flow from operations?
- What is the all time high TTM CFO for Wave Life Sciences?
- What is Wave Life Sciences TTM CFO year-on-year change?
What is Wave Life Sciences annual cash flow from operations?
The current annual CFO of WVE is -$19.43 M
What is the all time high annual CFO for Wave Life Sciences?
Wave Life Sciences all-time high annual cash flow from operations is -$3.55 M
What is Wave Life Sciences annual CFO year-on-year change?
Over the past year, WVE annual cash flow from operations has changed by +$108.35 M (+84.79%)
What is Wave Life Sciences quarterly cash flow from operations?
The current quarterly CFO of WVE is -$46.48 M
What is the all time high quarterly CFO for Wave Life Sciences?
Wave Life Sciences all-time high quarterly cash flow from operations is $85.52 M
What is Wave Life Sciences quarterly CFO year-on-year change?
Over the past year, WVE quarterly cash flow from operations has changed by -$12.02 M (-34.89%)
What is Wave Life Sciences TTM cash flow from operations?
The current TTM CFO of WVE is -$140.62 M
What is the all time high TTM CFO for Wave Life Sciences?
Wave Life Sciences all-time high TTM cash flow from operations is -$1.62 M
What is Wave Life Sciences TTM CFO year-on-year change?
Over the past year, WVE TTM cash flow from operations has changed by -$120.98 M (-616.26%)